INSIGHTS ON UPSTREAM MANUFACTURING
-
Engineering Reliability In Cell Therapy Manufacturing
A cell therapy manufacturing model built on precision planning, digital execution, lifecycle‑ready CMC systems, and transparent collaboration to achieve high reliability and reduce variability across programs.
-
Fab Antibody Fragment Titer Improvement
Learn how systematic screening of unique expression strains and plasmid combinations can overcome low protein yields, achieving active Fab titers over 4 g/L.
-
How Do You Protect Incubation Workflows From Contamination And Downtime?
Active HEPA filtration protects cell cultures by restoring air quality within minutes. Learn how continuous purification reduces contamination risks and ensures reliable, reproducible research.
-
Enhancing Biopharma ROI With In-House Long-Read Sequencing
Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.
-
NGS-Based Assays In CGT: Enhancing Product Development1/29/2026
Examine how NGS brings essential clarity to cell and gene therapy development by enabling sensitive biosafety testing, detailed genetic characterization, and reliable stability monitoring.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return1/29/2026
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Enabling NGS-Based Product Characterization And Biosafety Assays1/29/2026
Evolving regulations are shaping the adoption of NGS for biosafety and product characterization. Learn what teams must consider when validating modern sequencing assays within GMP‑regulated environments.
-
Advanced NGS Techniques For Cell Line Characterization In CGT1/29/2026
Discover how in‑house NGS and robust data management streamline CQA analysis, reduce risk, and strengthen development workflows from early research through manufacturing.
UPSTREAM MANUFACTURING SOLUTIONS
-
Simplify and intensify upstream bioprocessing. The XCell® ATF System, in single-use or stainless steel format, delivers superior cell retention. High impact upstream applications include N-1 perfusion, high productivity harvest, long-term perfusion and seed train intensification.
-
Game-changing TFDF® (Tangential Flow Depth Filtration) technology that simplify and intensify upstream viral vector bioprocessing, ideal for AAV, lentivirus, oncolytic, retrovirus, adenovirus, exosomes, and cells on microcarriers.
-
Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture, allowing for longer run times, higher product yields, and reduced costs.
-
Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.
-
Learn about high-performance and scalable THESYS OS oligosynthesizers, which feature advanced process controls and automation for efficient and reliable oligonucleotide synthesis.